Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Study results from Texas A&M University, Department of Veterinary Pathobiology broaden understanding of immunization
February 25th, 2009
Scientists discuss in 'The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle' new findings in immunization. According to a study from the United States, "Brucellosis is an important zoonotic disease of nearly worldwide distribution. Despite the availability of live vaccine strains for bovine (S19, RB51) and small ruminants (Rev-1), these vaccines have several drawbacks, including residual virulence for animals and humans." "Safe and efficacious immunization systems are therefore needed to overcome these disadvantages. A vjbR knockout was...
Source: Vaccine Weekly (2009-02-25)
|
